Then, combining their results with our results about TC2N inhibits FASN in all BC cell lines with different subtypes, we here from a side explains that the existence of TC2N is probably used for blocking neddylated PTEN/FASN axis-mediated tumor progression in all the four subtypes of BC. Here, FASN is linked to breast cancer.